Regulatory Issues in Chromatographic Analysis in the Pharmaceutical Industry

References

• 1994 . Reviewer Guidance: Validation of Chromatographic Methods Food and Drug Administration: Center for Drug Evaluation and Research .
   Google Scholar
• 1997 . Code of Federal Regulations (21 CFR) Washington, DC : Food and Drug Administration .
   Google Scholar
• 1996 . Federal Register 21 CFR Parts 210 and 211 Current Good Manufacturing Practice: Amendment of Certain Requirements for Finished Pharmaceuticals; Proposed Rule Vol. 61 , 20104 – 20115 . Food and Drug Administration . 87
   Google Scholar
• 2000 . Guidance for Industry: Analytical Procedures and Methods Validation. Chemistry, Manufacturing, and Controls Documentation. Draft Guidance: Validation of Chromatographic Methods Food and Drug Administration .
   Google Scholar
• 1987 . Guidance for Industry: Guideline for Submitting Samples and Analytical Data for Methods Validation Food and Drug Administration .
   Google Scholar
• 2003 . Guidance for Industry: Drug Product: Chemistry Manufacturing, and Controls Information Food and Drug Administration .
   Google Scholar
• 1987 . Guidance for Industry: Format and Content of the Chemistry, Manufacturing and Controls Section of an Application Food and Drug Administration .
   Google Scholar
• 1995 . Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well‐Characterized, Therapeutic, Biotechnology‐Derived Products Food and Drug Administration .
   Google Scholar
• 2003 . Guidance for Industry: INDs for Phase 2 and Phase 3 Studies Food and Drug Administration .
   Google Scholar
• 1994 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 1994 . Text on Validation of Analytical Procedures: Q2A. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1996 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 1996 . Validation of Analytical Procedures: Methodology Q2B. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1999 . Guidance for Industry: Changes to an Approved NDA or ANDA Food and Drug Administration .
   Google Scholar
• 2003 . Guidance for Industry: Comparability Protocols – Chemistry, Manufacturing and Controls Information Food and Drug Administration .
   Google Scholar
• 1999 . Guidance for Industry: Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Vaccine or Related Product Food and Drug Administration: Center for Biologics Evaluation and Research .
   Google Scholar
• 1999 . Guidance for Industry: Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Biological In Vitro Diagnostic Product Food and Drug Administration: Center for Biologics Evaluation and Research .
   Google Scholar
• 1999 . Guidance for Industry: Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for Human Plasma‐Derived Biological Products, Animal Plasma or Serum‐Derived Product Food and Drug Administration: Center for Biologics Evaluation and Research .
   Google Scholar
• 1998 . Guidance for Industry: Submission of Chemistry, Manufacturing and Controls Information for Synthetic Peptide Substance Food and Drug Administration .
   Google Scholar
• 1995 . Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well‐Characterized, Therapeutic, Biotechnology‐derived Products Food and Drug Administration .
   Google Scholar
• 1997 . Guidance for Industry: Changes to an Approved Application for Specified Biotechnology and Specified Synthetic Biological Products Food and Drug Administration .
   Google Scholar
• 1997 . Guidance for Industry: Changes to an Approved Application: Biological Products Food and Drug Administration: Center for Biologics Evaluation and Research .
   Google Scholar
• 2003 . Guidance for Industry: Comparability Protocols – Protein Drug Products and Biological Products – Chemistry, Manufacturing, and Controls Information Food and Drug Administration .
   Google Scholar
• 1997 . Guidance for Industry: Changes to an Approved Application for Specified Biotechnology and Specified Synthetic Biological Products Food and Drug Administration .
   Google Scholar
• 1996 . FDA Guidance Concerning Demonstration of Comparability of Human Biological Products, Including Therapeutic Biotechnology‐Derived Products Food and Drug Administration .
   Google Scholar
• 1994 . Reviewer Guidance: Validation of Chromatographic Methods Food and Drug Administration: Center for Drug Evaluation and Research .
   Google Scholar
• 2001 . Guidance for Industry: Bioanalytical Method Validation Food and Drug Administration .
   Google Scholar
• 2003 . United States Pharmacopeia: USP 26. The National Formulary: NF 21 Washington, DC : United States Pharmacopeial Convention .
   Google Scholar
• 1999 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 1999 . Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1999 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 1999 . Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products Q6B. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 2002 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 2002 . The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality—M4Q. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1993 . Council Directive 93/39/EEC Council of European Communities .
   Google Scholar
• 1975 . Council Directive 75/318/EEC Council of European Communities .
   Google Scholar
• 1991 . Commission Directive 91/507/EEC Council of European Communities .
   Google Scholar
• 1998 . VICH Topic GL1 (Validation: Definition), Guideline on Validation of Analytical Procedures: Definition and Terminology European Agency for the Evaluation of Medicinal Products .
   Google Scholar
• 1998 . VICH Topic GL2 (Validation: Methodology), Guideline on Validation of Analytical Procedures: Methodology European Agency for the Evaluation of Medicinal Products .
   Google Scholar
• 2002 . European Pharmacopoeia , 4th Ed.
   Google Scholar
• Shabir , G. A. 2003 . Validation of high‐performance liquid chromatography methods for pharmaceutical analysis: understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization . J. Chromatogr. A , 987 : 57 – 66 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• 2000 . Guidance for Industry: NDAs: Impurities in Drug Substances Food and Drug Administration .
   Google Scholar
• 2002 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 2002 . Impurities in New Drug Substances Q3A(R). Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1999 . Guidance for Industry: ANDAs: Impurities in Drug Substances Food and Drug Administration .
   Google Scholar
• 2003 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 2003 . Impurities in New Drug Products Q3B(R). Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• 1997 . International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use . 1997 . Impurities: Guideline for Residual Solvents Q3C. Recommended for Adoption at Step 4 of the ICH Process ,
   Google Scholar
• Ahuja , S. 1998 . “ Regulations and requirements for controlling impurities ” . In Impurities Evaluation of Pharmaceutical 16 – 41 . New York : Marcel Dekker, Inc. .
   Google Scholar
• Jenke , D. R. 1996 . Chromatographic method validation: a review of current practices and procedures. I. General concepts and guidelines . J. Liq. Chromatogr. Rel. Technol. , 19 ( 5 ) : 719 – 736 .
   Web of Science ®Google Scholar
• Clarke , G. S. 1994 . The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratories . J. Pharm. Biomed. Anal. , 12 ( 5 ) : 643 – 652 . [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Jenke , D. R. 1996 . Chromatographic method validation: a review of current practices and procedures. II. Guidelines for primary validation parameters . J. Liq. Chromatogr. Rel. Technol. , 19 ( 5 ) : 737 – 757 .
   Web of Science ®Google Scholar
• Rathore , A. S. , Kurumbail , R. R. and Lasdun , A. M. 2002 . Requirements for validating a capillary isoelectric focusing method for impurity quantitation . LCGC N.A. , 20 ( 11 ) : 1042 – 1048 .
   Web of Science ®Google Scholar
• Crowther , J. B. 2001 . “ Validation of pharmaceutical methods ” . In Handbook of Modern Pharmaceutical Analysis Edited by: Ahuja , S. and Scypinski , S. 415 – 443 . San Diego : Academic Press .
   Google Scholar
• Buick , A. R. , Doig , M. V. , Jeal , S. C. , Land , G. S. and McDowall , R. D. 1990 . Method validation in the bioanalytical laboratory . J. Pharm. Biomed. Anal. , 8 ( 8–12 ) : 629 – 637 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jimidar , M. , Hartmann , C. , Cousement , N. and Massart , D. L. 1995 . Determination of nitrate and nitrite in vegetables by capillary electrophoresis with indirect detection . J. Chromatogr. A , 706 : 479 – 492 . [CROSSREF]
   Web of Science ®Google Scholar
• Shah , V. P. , Midha , K. K. , Dighe , S. , McGilveray , I. J. , Skelly , J. P. , Yacobi , A. , Layloff , T. , Viswanathan , C. T. , Cook , C. E. , McDowall , R. D. , Pittman , K. A. and Spector , S. 1991 . Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies . European J. Drug Metab. Pharmacokinetics , 16 ( 4 ) : 249 – 255 .
   PubMed Web of Science ®Google Scholar
• Shah , V. P. , Midha , K. K. , Findlay , J. W.A. , Hill , W. M. , Hulse , J. D. , McGilveray , I. J. , McKay , G. , Miller , K. J. , Patnaik , R. N. , Powell , M. L. , Tonelli , A. , Viswanathan , C. T. and Yacobi , A. 2000 . Bioanalytical method validation: a revisit with a decade of progress . Pharm. Res. , 17 ( 12 ) : 1551 – 1557 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMedGoogle Scholar
• Qi , M. , Chen , R. , Cong , R. and Wang , P. 2003 . A validated method for simultaneous determination of piperacillin sodium and sulbactam sodium in sterile powder for injection by HPLC . J. Liq. Chromatogr. Rel. Technol. , 26 ( 4 ) : 665 – 676 . [CROSSREF]
   Web of Science ®Google Scholar
• Ferretti , R. , Gallinella , B. , La Torre , F. and Turchetto , L. 1998 . Validated chiral high‐performance liquid chromatographic method for the determination of trans‐(−)‐paroxetine and its enantiomer in bulk and pharmaceutical formulations . J. Chromatog. B , 710 : 157 – 164 . [CSA]
   PubMed Web of Science ®Google Scholar
• Mouatassim‐Souali , A. , Tamisier‐Karolak , S. L. , Perdiz , D. , Cargouet , M. and Levi , Y. 2003 . Validation of a quantitative assay using GC/MS for trace determination of free and conjugated estrogens in environmental water samples . J. Sep. Sci. , 26 : 105 – 111 . [CROSSREF]
   Web of Science ®Google Scholar
• 1989 . Guidelines for collaborative study procedure to validate characteristics of a method of analysis . J. Assoc. Off. Anal. Chem. , 72 ( 4 ) : 694 – 704 .
   Google Scholar
• Ziaková , A. and Brandšteterová , E. 2003 . Validation of HPLC determination of phenolic acids present in some Lamiaceae family plants . J. Liq. Chromatogr. Rel. Technol. , 26 ( 3 ) : 443 – 453 . [CROSSREF]
   Web of Science ®Google Scholar
• Bressolle , F. , Bromet‐Petit , M. and Audran , M. 1996 . Validation of liquid chromatographic and gas chromatographic methods: application to pharmacokinetics . J. Chromatogr. B , 686 : 3 – 10 .
   PubMed Web of Science ®Google Scholar
• Tamisier‐Karolak , S. L. , Tod , M. , Bonnardel , P. , Czok , M. and Cardot , P. 1995 . Daily validation procedure of chromatographic assay using gaussoexponential modeling . J. Pharm. Biomed. Anal. , 13 : 959 – 970 . [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Thompson , M. , Ellison , S. L. and Wood , R. 2002 . Harmonized guidelines for single‐laboratory validation of methods of analysis (IUPAC Technical Report) . Pure Appl. Chem. , 74 ( 5 ) : 835 – 855 .
   Web of Science ®Google Scholar
• Izco , J. M. , Tormo , M. , Harris , A. and Tong , P. S. 2003 . Optimization and validation of a rapid method to determine citrate and inorganic phosphate in milk by capillary electrophoresis . J. Dairy Sci. , 86 ( 1 ) : 86 – 95 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Rabouan , S. , Olivier , J. C. , Guillemin , H. and Barthes , D. 2003 . Validation of HPLC analysis of aspartate and glutamate neurotransmitters following o‐phthaldialdehyde‐mercaptoethanol derivatization . J. Liq. Chromatogr. Rel. Technol. , 26 ( 11 ) : 1797 – 1808 . [CROSSREF]
   Web of Science ®Google Scholar
• Bruce , P. , Minkkinen , P. and Riekkola , M. L. 1998 . Practical method validation: validation sufficient for an analysis method . Mikrochimica Acta , 128 ( 1–2 ) : 93 – 106 .
   Web of Science ®Google Scholar
• Fabre , H. and Altria , K. D. 2001 . Key points for validating CE methods, particularly in pharmaceutical analysis . LCGC , 19 ( 5 ) : 498 – 505 .
   Web of Science ®Google Scholar
• Castillo , M. A. and Castells , R. C. 2001 . Initial evaluation of quantitative performance of chromatographic methods using replicates at multiple concentrations . J. Chromatogr. A , 921 : 121 – 133 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jenke , D. R. 1996 . Chromatographic method validation: a review of current practices and procedures. III. Ruggedness, revalidation and system suitability . J. Liq. Chromatogr. Rel. Technol. , 19 ( 12 ) : 1873 – 1891 .
   Web of Science ®Google Scholar
• Barwick , V. J. 1998 . Review of Sources of Uncertainty in Gas Chromatography and High Performance Liquid Chromatography LGC/VAM .
   Google Scholar
• Virrlichie , J. L. and Ayache , A. 1995 . A ruggedness test model and its application for HPLC method validation . STP Pharma Practiques , 5 ( 1 ) : 49 – 60 .
   Google Scholar
• Hokanson , G. C. 1994 . A life cycle approach to the validation of analytical methods during pharmaceutical product development, part II: changes and the need for additional validation . Pharm. Technol. , 18 ( October ) : 92 – 100 .
   Google Scholar
• Lee , K. R. , Bongers , J. , Gulati , D. and Burman , S. 2000 . Statistical validation of reproducibility of HPLC peptide mapping for the identity of an investigational drug compound based on principal component analysis . Drug Develop. Ind. Pharm. , 26 ( 10 ) : 1045 – 1057 . [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Szepesi , G. 1990 . “ Quantitation in thin‐layer chromatography ” . In Modern Thin Layer Chromatography Edited by: Grinberg , N. 249 – 284 . New York : Marcel Dekker, Inc. .
   Google Scholar
• Needham , S. 2003 . Bioanalytical method validation: example, HPLC/MS/MS bioanalysis of an anti‐nerve gas agent drug for homeland security . Amer. Pharm. Rev. , 6 ( 2 ) : 86 – 91 . [CSA]
   Google Scholar
• Grisanti , V. and Zachowski , E. J. 2002 . Operational and performance qualification . LCGC N.A. , 20 ( 4 ) : 356 – 362 . [CSA]
   Web of Science ®Google Scholar
• Zanetti , M. and Huber , L. 1996 . Validating automated analytical instruments to meet regulatory and quality standard regulations . Mikrochim. Acta , 123 ( 1–4 ) : 23 – 31 .
   Google Scholar
• Burgess , C. , Jones , D. G. and McDowall , R. D. 1998 . Equipment qualification for demonstrating the fitness for purpose of analytical instrumentation . Analyst , 123 : 1879 – 1966 . [CROSSREF]
   Web of Science ®Google Scholar
• Bedson , P. 1998 . Guidance on Equipment Qualification of Analytical Instruments: High Performance Liquid Chromatography (HPLC) LGC/VAM Instrumentation Working Group .
   Google Scholar
• Hall , G. and Dolan , J. W. 2002 . Performance qualification of LC systems . LCGC N.A. , 20 ( 9 ) : 842 – 848 .
   Web of Science ®Google Scholar
• Rathore , A. S. , Kennedy , R. M. , O'Donnell , J. K. , Bemberis , I. and Kaltenbrunner , O. 2003 . Qualification of a chromatographic column why and how to do it . Biopharm. Intl. , 16 ( March ) : 30 – 40 .
   Google Scholar
• Huber , L. 1999 . Validation and Qualification in Analytical Laboratory Buffalo Grove , IL : Interpharm Press .
   Google Scholar
• Huber , L. and Welebob , L. 1997 . Selecting parameters and limits for equipment operational qualification . Accred. Qual. Assur. , 2 ( 7 ) : 316/322 [CROSSREF]
   Web of Science ®Google Scholar
• Furmann , W. B. , Layloff , R. F. and Tetzlaff , R. F. 1994 . Validation of computerized liquid chromatographic systems . J. AOAC Intl. , 77 ( 5 ) : 1314 – 1318 .
   Web of Science ®Google Scholar
• 1983 . Guide to Inspection of Computerized Systems in Drug Processing Food and Drug Administration .
   Google Scholar
• 2001 . Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Validation Food and Drug Administration .
   Google Scholar
• 2001 . Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Glossary of Terms Food and Drug Administration .
   Google Scholar
• 2002 . Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Time Stamps Food and Drug Administration .
   Google Scholar
• 2002 . Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Maintenance of Electronic Records Food and Drug Administration .
   Google Scholar
• 2002 . Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Electronic Copies of Electronic Records Food and Drug Administration .
   Google Scholar
• 2003 . Guidance for Industry: Part 11, Electronic Records; Electronic Signatures—Scope and Application Food and Drug Administration .
   Google Scholar
• 1999 . Guidance for Industry: Computerized Systems Used in Clinical Trial Food and Drug Administration .
   Google Scholar
• 2002 . General Principles of Software Validation; Final Guidance for Industry and FDA Staff Food and Drug Administration .
   Google Scholar
• 2001 . The Good Automated Manufacturing Practoce (GAMP) Guide for Validation of Automated Systems; GAMP 4 ISPE/GAMP Forium .
   Google Scholar
• Huber , L. 1995 . Validation of Computerized Analytical Laboratories Englewood , CO : Interpharm Press .
   Google Scholar
• Hoffmann , A. , Kähny‐Simonius , J. , Plattner , M. , Schmidli‐Vvckovski , V. and Kronseder , C. 1998 . Computer system validation: an overview of official requirements and standards . Pharm. Acta Helv. , 72 : 317 – 325 . [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar
• Beizer , B. 1995 . Black Box Testing, Techniques for Functional Testing of Software and Systems New York : Wiley & Sons .
   Google Scholar
• Hetzel , B. 1988 . The Complete Guide to Software Testing , 2nd Ed. Wellesley , MA : QED Information Sciences .
   Google Scholar
• Kaner , C. , Falk , J. and Nguyen , H. Q. 1999 . Testing Computer Software , 2nd Ed. New York : Wiley & Sons .
   Google Scholar